Adjuvant Bevacizumab
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension (NCT06515678) | Groupe Hospitalier Pitie-Salpetriere | 2024-05-20 |
Track Adjuvant Bevacizumab automatically
Every clearance here is in the API, with alerts when new ones post.